Press release
Heart Valves Market Size And Global Industry Forecast 2034
Heart Valves Market
Market Overview: Saving Hearts, Extending Lives
Heart valve diseases, including stenosis and regurgitation, affect millions of patients worldwide, especially older adults. Heart valve replacement and repair devices are essential to restoring proper cardiac function. With innovations such as Transcatheter Aortic Valve Replacement (TAVR) and minimally invasive surgery gaining widespread acceptance, the market is entering a high-growth phase-balancing clinical efficacy, safety, and patient recovery.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/67013
Key Market Highlights:
• 2024 Market Size: USD 11.8 Billion
• 2034 Forecasted Market Size: USD 25.4 Billion
• CAGR (2024-2034): 7.9%
• Growth Drivers: Aging population, increasing prevalence of valvular diseases, preference for minimally invasive therapies, and improved implant durability
• Key Companies: Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, LivaNova
Segmentation Analysis
By Type:
• Mechanical Heart Valves
• Biological/Tissue Heart Valves
• Transcatheter Heart Valves
By Position:
• Aortic Valve
• Mitral Valve
• Pulmonary Valve
• Tricuspid Valve
By Procedure:
• Open-Heart Surgery
• Minimally Invasive Surgery
• Transcatheter Valve Replacement (TAVR/TAVI)
By End Use:
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Research Institutes
Summary: Transcatheter heart valves are the fastest-growing segment due to their non-invasive nature and suitability for high-risk or elderly patients. The aortic valve position accounts for the largest share, driven by the global adoption of TAVR. While mechanical valves offer long-term durability, biological valves dominate in volume due to their reduced need for lifelong anticoagulation.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=67013
Regional Analysis
North America:
• Dominates global revenues, led by high procedure volumes in the U.S. and Canada.
• Widespread adoption of TAVR, supported by strong reimbursement and FDA approvals.
• High incidence of age-related aortic stenosis.
Europe:
• Germany, France, and the UK lead in valve replacements.
• EU-backed cardiovascular health initiatives and clinical trials boost innovation.
• Strong focus on minimally invasive cardiac surgery and public health coverage.
Asia-Pacific:
• Fastest-growing region with CAGR above 9.1%.
• Rapid expansion of cardiac care infrastructure in India, China, and Southeast Asia.
• Increasing awareness, aging demographics, and rising healthcare investments.
Latin America:
• Brazil and Mexico are key markets, driven by public-private cardiac care programs.
• Growing access to advanced heart centers and surgical expertise.
Middle East & Africa:
• GCC countries investing in advanced cardiac surgery centers and medical tourism.
• Gradual increase in procedure volumes due to CVD prevalence and aging populations.
Regional Summary: North America remains the innovation hub, but Asia-Pacific emerges as the most dynamic growth region, driven by infrastructure expansion, affordability trends, and growing procedural awareness.
Market Dynamics
Key Growth Drivers:
• Aging Population: By 2050, over 2 billion people will be over 60 years old, a group most vulnerable to valvular diseases.
• Minimally Invasive Procedure Preference: TAVR and other catheter-based approaches reduce surgical risk and recovery time.
• Technological Innovations: Advancements in valve design, materials (e.g., bovine pericardium, polymer-based valves), and delivery systems.
• Rising Burden of Rheumatic and Degenerative Valve Disease: Particularly in developing regions.
Key Challenges:
• High Cost of Devices and Procedures: Especially transcatheter valves, which limits adoption in lower-income countries.
• Durability Concerns with Bioprosthetic Valves: Especially for younger patients requiring long-term solutions.
• Regulatory and Clinical Hurdles: Ensuring safety, performance, and long-term efficacy requires extensive trials and oversight.
Latest Trends:
• Expansion of TAVR to Low-Risk Patients: Initially restricted to high-risk individuals, now widely available to broader patient groups.
• Next-Gen Valve Technologies: Sutureless valves, repositionable delivery systems, and synthetic valve materials.
• AI and Imaging Integration: Advanced imaging assists in precise valve sizing and placement.
• Valve-in-Valve Procedures: Emerging option for failed bioprosthetic valve replacements without repeat surgery.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/67013/heart-valves-market
Competitor Analysis
Leading Companies:
• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• CryoLife, Inc. (Artivion)
• MicroPort Scientific Corporation
• JenaValve Technology, Inc.
• Braile Biomédica
• TTK Healthcare Ltd.
• Colibri Heart Valve LLC
• Sorin Group
• Meril Life Sciences
• ValveXchange, Inc.
• Xeltis AG
• Peijia Medical
• Lepu Medical Technology
• Symetis SA
• Biostar Technologies Ltd.
• Biosensors International
Competitive Summary: The market is highly concentrated, with leaders like Edwards Lifesciences and Medtronic commanding large shares through strong TAVR portfolios. Emerging players, especially in Asia and Europe, are introducing cost-effective and region-specific technologies. R&D focus includes durable bioprosthetics, valve-in-valve solutions, and synthetic valve scaffolds.
Conclusion: A New Era for Heart Valve Interventions
The global heart valves market is on the cusp of a revolution, where minimally invasive, personalized, and AI-supported procedures will define the next decade. With a strong push from aging populations, expanding access to cardiac care, and breakthrough innovations, the market outlook is both optimistic and transformative.
This report is also available in the following languages : Japanese (心臓弁市場), Korean (심장 판막 시장), Chinese (心脏瓣膜市场), French (Marché des valves cardiaques), German (Markt für Herzklappen), and Italian (Mercato delle valvole cardiache), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/67013
Our More Report:
Prolactin ELISA Test Kit Market
https://exactitudeconsultancy.com/reports/65907/prolactin-elisa-test-kit-market
Beta-Human Chorionic Gonadotropin (HCG) ELISA Test Kit Market
https://exactitudeconsultancy.com/reports/65909/beta-human-chorionic-gonadotropin-hcg-elisa-test-kit-market
Thyroid Stimulating Hormone (TSH) ELISA Test Kit Market
https://exactitudeconsultancy.com/reports/65913/thyroid-stimulating-hormone-tsh-elisa-test-kit-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Valves Market Size And Global Industry Forecast 2034 here
News-ID: 4131634 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for Valve
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
The availability of abundant natural resources, such as petroleum and shale gas, in Australia is expected to provide profitable opportunities for the Australia pressure safety valve market. Moreover, the government‐™s initiative to encourage offshore exploration of minerals deposits could further boost the business opportunities for market players in Australia. The presence of a wide oil & gas distribution network continues to provide a steady stream of revenue to market players;…
Control Valve Market by Region - North America, Latin America, Europe, Japan, AP …
Increasing penetration of automation across several industrial verticals has fuelled the demand for components that regulate pressure, temperature and other elements effectively. Manufacturers are advancing their capabilities in developing control valves for the future industrial demands. New designs are being incorporated to increase the efficiency of control valves in enabling a direct control of the flow rate, and in processing the information on liquid level, temperature and pressure.
According to Fact.MR’s…
Australian Pressure Safety Valve Market by Offering (Safety Valve and Safety Val …
Australian pressure safety valve market size is expected to reach $65.38 million by 2025 from $52.12 million in 2017, growing at a CAGR of 2.88% during the forecast period (2018–2025). Pressure safety valves (pressure relief valves) are specially designed valves that regulate the surge in pressure within the pressure systems, which otherwise could hinder industrial processes. The valves have outlets that guide the additional flow of fluids or gases, which…
Control Valve Market Analysis Report by Region - North America, Latin America, E …
Fact.MRs’ latest forecast study assesses that the global control valve market will expand steadily during the forecast period, 2017-2026. Increasing industrialization and growing use of pneumatics in mechanical processes will drive the adoption of control valves to a considerable extent. The global control valve market will register expansion at a 5.4% CAGR in terms of volume over, the forecast period. By the end of 2026, control valves worth over US$ 15.5 Bn…
Bleed Valve Market 2017-Eaton, Weir Group, KSB, Mahle, Mogas, Alfa Laval, Nihon …
Apex Research, recently published a detailed market research study focused on the "Bleed Valve Market" across the global, regional and country level. The report provides 360° analysis of "Bleed Valve Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bleed Valve industry, and estimates the future trend of Bleed Valve market…
Global Plug Valves Market: Yuandong Valve, Yuanda Valve, Weir, Walworth, Zhengqu …
Global Market Study Evaluate on Plug Valves Industry by Type, Manufacturers, Application, Type, and Regions, Forecast up to 2022
The scope of the global Plug Valves market report is:
This report offers a comprehensive evaluation of the Plug Valves market. It does so by in-depth qualitative insights, historical Plug Valves market data, and verifiable projections about global Plug Valves market size. The projections featured in the Plug Valves market report have been…
